Smith & Nephew, Inc.

Smith & Nephew, Inc. Advanced Wound Management Division, a subsidiary of UK-based Smith & Nephew PLC, supplies negative pressure wound therapy systems, advanced wound dressings, orthopedic implants, patient monitoring systems, and related medical consumables to the Department of Veterans Affairs and the Defense Logistics Agency as a prime contractor (95% of recent awards) competing under full and open, unrestricted procurement with no set-aside designations.

The division's federal footprint centers on Veterans Affairs, which accounts for the overwhelming majority of customer concentration by potential value. The Department of Veterans Affairs Headquarters holds eight awards valued at $2.13 billion combined potential value, driven primarily by two single-award indefinite delivery contracts awarded to Smith & Nephew by the Defense Logistics Agency Troop Support Medical in April 2025: a $75 million indefinite delivery contract for negative pressure wound therapy systems, related supplies, and accessories (SPE2D125DA005, ultimate completion April 8, 2035), and a companion $75 million indefinite delivery contract under the same vehicle (SPE2DV17D9289). These two DLA contracts anchor the vendor's entire federal pipeline and represent recompete risk and opportunity across a ten-year performance window. The Veterans Integrated Service Network 12 holds a $29.3 million Federal Supply Schedule contract (FSS-65-II-A, Medical Equipment and Supplies, July 1, 2024 through June 30, 2029) covering advanced wound care products, dressings, bandages, and negative pressure wound therapy devices including PROFORE bandaging systems, ACTICOAT antimicrobial products, and the RENASYS TOUCH negative pressure wound therapy device. Smith & Nephew also holds a $116.3 million Federal Supply Schedule contract under GSA schedule 65 I B (Pharmaceuticals and Drugs) through August 31, 2028, and a $1.245 million multiple-award Blanket Purchase Agreement for negative pressure wound therapy rental systems serving VISN 5 (Maryland, West Virginia, and Washington D.C.) through July 31, 2030.

Customer concentration by award count reveals fragmentation across Veterans Integrated Service Networks, with the top five customers (VISN 17, VISN 23, VISN 10, VISN 2, and DLA Troop Support Medical) representing 40% of awards but only a small share of dollar value outside the DLA contracts. The largest regional customers include VISN 12 (17 awards, $185.6 million), VISN 1 (7 awards, $50.1 million), and VISN 5 (10 awards, $1.4 million), with the remaining 28 VISNs and federal customers placing smaller individual orders. This split between order volume and dollars reflects a business model anchored to two major DLA indefinite delivery vehicles that feed delivery orders to regional VA networks and other federal health care centers, supplemented by direct delivery orders and BPA calls from individual VA medical centers.

Activity has remained modest in recent years — five awards in 2026 year-to-date, ten in 2025, seven in 2024 — with 267 total prime and sub awards in the source data spanning from 2008 to June 2026. Only one award is scheduled for completion within the next twenty-four months (combined potential value $26 thousand), indicating minimal recompete exposure in the near term; the two $75 million DLA contracts run through April 8, 2035, and the FSS and BPA vehicles run through 2028–2030. The division's work is overwhelmingly product sales rather than services, grounded in NAICS 339112 (Surgical Appliance and Supplies Manufacturing), with 131 awards in that code, followed by medical and surgical instrument manufacturing and pharmaceutical preparation manufacturing.

Smith & Nephew subcontracts to Cardinal Health 200, LLC on medical and surgical equipment and supplies orders, with 13 sub-awards visible in the source spanning from August 2022 to December 2025, typically for wound dressing materials, surgical consumables, and regional distribution support. The sub-award relationship represents a minority of the division's footprint (5% of total awards) and appears to be distribution-channel activity rather than strategic subcontracting for core capability.

Place of performance centers on the division's facilities in Fort Worth, Texas (primary administrative and manufacturing location), Benbrook, Texas, and Memphis, Tennessee, with products sourced from manufacturing facilities in the United States, Canada, Sweden, and the United Kingdom. Recent representative prime contract work includes a $1.08 million firm fixed-price purchase order from VA VISN 12 for LEAF Patient Sensors (October 2025, base through September 2026 with two 12-month option periods), a $223.5 million delivery order from VA VISN 23 for Wound Vacuum equipment under the Medical Equipment and Supplies FSS (September 2025), a $43 thousand delivery order from DLA Medical Supply Chain for RENASYS TCH nonconnective fourth-edition wound care technology (February 2026), and multiple LEAF Sensors Patient Mobility System BPA calls to VISN 12 ranging from $360 thousand to $1.188 million annually (October 2023 through September 2025).